Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors

被引:37
作者
Li, LJ
Jönsson-Rylander, AC
Abe, K
Zukowska, Z
机构
[1] Georgetown Univ, Dept Physiol & Biophys, Med Ctr, Washington, DC 20057 USA
[2] AstraZeneca, Molndal, Sweden
关键词
stress; neuropeptide Y; Y1 receptor antagonist; atherosclerosis; angioplasty;
D O I
10.1161/01.ATV.0000179601.19888.19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - We reported previously that neuropeptide Y (NPY) induces an atherosclerotic-like lesion that is significantly reduced by NPY-Y1 and NPY-Y5 receptor ( R) inhibitors. Because antagonists also inhibit neointima induced by angioplasty alone, we now test whether stress-induced endogenous NPY release mimic these changes. Methods and Results - Rats were nonstressed or stressed ( 4 C water; 2 hours per day for 14 days) starting immediately before and continuing after carotid artery angioplasty. Stress acutely and chronically increased blood pressure and doubled plasma NPY levels. After 14 days, angioplasty-induced neointima was markedly greater in stressed ( than nonstressed) rats, in which most of the vessels became occluded with an atherosclerotic-like lesion containing macrophages, lipids, thrombus, and microvessels that was similar but more inflammatory than the injury in the NPY-treated vessels. Fourteen days after angioplasty combined with stress or NPY, Y1R and Y5R ( mRNA and protein) became upregulated in areas of neointima, microvessels, and macrophages in injured carotid arteries. Stress- and NPY-induced changes were completely prevented by a selective Y1R antagonist (0.02 mu mol/kg per minute for 14 days), whereas neointima induced by angioplasty alone was reduced by 60%. Conclusions - Because of sympathetic NPY release, stress may be a less-than-appreciated risk factor for restenosis/atherosclerosis, and Y1R antagonists a potential therapy for these conditions.
引用
收藏
页码:2075 / 2080
页数:6
相关论文
共 42 条
[1]   Relevance of Neuropeptide Y for the neuroimmune crosstalk [J].
Bedoui, S ;
Kawamura, N ;
Straub, RH ;
Pabst, R ;
Yamamura, T ;
von Hösten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 134 (1-2) :1-11
[2]   Stress and the inflammatory response: A review of neurogenic inflammation [J].
Black, PH .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (06) :622-653
[3]   Stress, inflammation and cardiovascular disease [J].
Black, PH ;
Garbutt, LD .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2002, 52 (01) :1-23
[4]   Neuropeptide Y, ubiquitous and elusive [J].
Chronwall, BA ;
Zukowska, Z .
PEPTIDES, 2004, 25 (03) :359-363
[5]   Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty [J].
Cipollone, F ;
Marini, M ;
Fazia, M ;
Pini, B ;
Iezzi, A ;
Reale, M ;
Paloscia, L ;
Materazzo, G ;
D'Annunzio, E ;
Conti, P ;
Chiarelli, F ;
Cuccurullo, F ;
Mezzetti, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :327-334
[6]  
DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259
[7]   Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing [J].
Ekstrand, AJ ;
Cao, RH ;
Björndahl, M ;
Nyström, S ;
Jönsson-Rylander, AC ;
Hassani, H ;
Hallberg, B ;
Nordlander, M ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6033-6038
[8]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595
[9]   NEUROPEPTIDE-Y STIMULATES PROLIFERATION OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS - COOPERATION WITH NORADRENALINE AND ATP [J].
ERLINGE, D ;
BRUNKWALL, J ;
EDVINSSON, L .
REGULATORY PEPTIDES, 1994, 50 (03) :259-265
[10]   Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease [J].
Esler, M ;
Kaye, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 :S1-S7